ARDELYX INC (ARDX) Stock News

USA - Nasdaq - NASDAQ:ARDX - US0396971071 - Common Stock

5.54 USD

-0.05 (-0.89%)

Last: 12/2/2025, 8:27:13 PM

5.6 USD

+0.06 (+1.08%)

After Hours: 12/2/2025, 8:27:13 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ARDX Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: The Motley Fool

Ardelyx (ARDX) Q3 2025 Earnings Call Transcript

13 days ago - By: The Motley Fool - Mentions: TDOC ORCL WGS BHVN ...

Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake?

25 days ago - By: Ardelyx, Inc.

Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week

25 days ago - By: Ardelyx, Inc.

Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week

a month ago - By: Stocktwits

News Image

Ardelyx Stock Slips After-Hours As $100M Shelf Filing Sparks Dilution Fears After Strong Q3

a month ago - By: Stocktwits - Mentions: IWV URTY

News Image

Ardelyx Shares Soar Premarket As CEO Sees Continued Demand For Blockbuster Drug Ibsrela

a month ago - By: Benzinga - Mentions: IR CDP ENTG BUD ...

Earnings Scheduled For October 30, 2025

2 months ago - By: Ardelyx, Inc.

Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025

a month ago - By: Ardelyx, Inc.

Ardelyx to Participate at the Jefferies Global Healthcare Conference in London

a month ago - By: Benzinga - Mentions: ADM NSP SRPT UUUU ...

Insperity Posts Downbeat Q3 Results, Joins IAC, Archer-Daniels-Midland And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

a month ago - By: Ardelyx, Inc.

Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference

a month ago - By: Ardelyx, Inc.

Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference

4 months ago - By: Stocktwits - Mentions: VFMO IWMW

News Image

Ardelyx Stock Soars On Price Target Hikes After Upbeat Q2 Report: Retail Sees More Revisions Coming

a month ago - By: Ardelyx, Inc.

Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

a month ago - By: Ardelyx, Inc.

Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

a month ago - By: Ardelyx, Inc.

Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology’s 2025 Annual Meeting

a month ago - By: Ardelyx, Inc.

Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology’s 2025 Annual Meeting

a month ago - By: Ardelyx, Inc.

Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology’s Kidney Week

a month ago - By: Ardelyx, Inc.

Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology’s Kidney Week

2 months ago - By: Ardelyx, Inc.

Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025

2 months ago - By: Ardelyx, Inc.

Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer

2 months ago - By: Ardelyx, Inc.

Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer

3 months ago - By: Yahoo Finance

Ardelyx, Inc. (ARDX) Strengthens Global Reach with Kyowa Kirin Deal

3 months ago - By: Ardelyx, Inc.

Ardelyx to Participate in Upcoming Investor Conferences

3 months ago - By: Ardelyx, Inc.

Ardelyx to Participate in Upcoming Investor Conferences

4 months ago - By: Zacks Investment Research

Ardelyx (ARDX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

4 months ago - By: Zacks Investment Research - Mentions: SXTP

Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates